Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.34.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.79ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-13571.9China
BN.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
FK.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-5579.54China
GJ.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used